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Dengue virus NS1 is a glycoprotein of 46–50 kDa which associates as a dimer to internal and cytoplasmic
membranes and is also secreted, as a hexamer, to the extracellular milieu. However, the notion exist that
NS1 is secreted only from infected vertebrate and not mosquito cells. In this work, evidence is presented
showing that NS1 is secreted efﬁciently by infected mosquito cells. NS1 was detected in cell supernatants
starting at 6 hpi with a continuous concentration increase up to 24 hpi. Nevertheless, cell viability
showed an average cell survival of 97%. At variance with observations with vertebrate cells, NS1 does not
seems to associate with the cytoplasmic membrane of insect cells. Finally, evidence is presented indi-
cating that NS1 is secreted from insect cells as a barrel-shaped hexamer. These ﬁndings provide new
insights into the biology of NS1 and open questions about the role of secreted NS1 in the vector mos-
quito.
& 2015 Elsevier Inc. All rights reserved.Introduction
Dengue is the most important mosquito borne viral disease to
humans. The dengue virus (DENV) belongs to the genus Flavivirus
within the family Flaviviridae. The virion is enveloped and the
genome consists of a single stranded RNA molecule of positive
polarity of approximately 11 Kb. The DENV genome encodes for
3 structural proteins (capsid, C; precursor membrane and mem-
brane prM/M; envelope, E) and for 7 non-structural proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, NS5), which are all derived from
the proteolytic processing of a poly-protein of approximately 3400
amino acids (Clyde and Harris, 2006). Viral replication occurs in
the cytoplasm in close association with the rough endoplasmic
reticulum (RER) and involves the NS proteins as well as the
assistance of cellular proteins, for replication, translation and
encapsidation of the genome, and for the proper folding of the
viral proteins (Clyde and Harris, 2006). Despite the great disease
burden associated with dengue, currently there are neitherca y Patogénesis Molecular,
VESTAV-IPN), Av. IPN 2508,
ico.
.vaccines nor speciﬁc treatment for the disease (Whitehorn and
Simmons, 2011).
NS1 is a glycoprotein of approximately 46–50 kDa, highly
conserved among the 4 DENV serotypes and even among arthro-
pod borne ﬂaviviruses (Muller and Young, 2013; Amorim et al.,
2014). Monomeric NS1 is released into the lumen of the ER after
cleavage from E and NS2A. In the infected cell, NS1 is found mainly
as a dimer associated to intracellular membranes and organelles
induced by the virus infection; however, a small fraction of NS1
can also be found associated with lipid rafts on the plasma
membrane or soluble, secreted into the supernatant (Winkler
et al., 1988; Alcon-LePoder et al., 2006; Muller and Young, 2013).
Membrane associated NS1 is a homodimer and since NS1 lacks
membrane anchoring domains its association with plasma mem-
brane is probably GPI mediated (Noisakran et al., 2008; Akey et al.,
2014). Secreted NS1 is a hexamer with characteristics that
resemble the human high density lipoprotein (Flamand et al. 1999;
Gutsche et al. 2011). The crystal structure of the full length NS1
protein revealed a surface with a marked hydrophobic character
on one face of the dimer. In agreement, recombinant NS1 has the
capacity to bind to lipid bilayers and to remodel large liposomes to
small particles (Akey et al., 2014). NS1 is also secreted by cells
infected with other ﬂaviviruses such as yellow fever, West Nile
virus or Japanese encephalitis virus (Mason, 1989; Alcon-LePoder
et al., 2006). NS1 appears to be essential for viral viability, and has
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although its role in DENV the replication is largely unknown.
Indirect evidence suggests that NS1 is a necessary cofactor for viral
RNA replication and virion morphogenesis (Fan and Mason, 1990;
Clyde and Harris, 2006; Noisakran et al., 2008; Muller and Young,
2013).
High levels of NS1 are found in the sera of DENV infected
patients early during infection and evidence exist suggesting that
NS1 is related to DHF pathogenesis (Whitehorn and Simmons,
2011; Muller and Young, 2013; Halstead, 2013; Amorim et al.,
2014). Fundamental characteristics that distinguish the FHD from
the more benign forms of the disease are hemorrhage, coagulo-
pathy and a sharp increase in vascular permeability. High levels of
circulating NS1 in sera correlate with disease severity and risk of
progression to DHF (Libraty et al., 2002; Avirutnan et al., 2006; De
la Cruz et al., 2013). Several mechanisms have been proposed to
explain the participation of NS1 in DHF such as the capacity of NS1
to form complexes with prothrombin/thrombin, to activate the
complement cascade either directly or throughout circulating
immune complexes or the existence of anti-NS1 antibodies cross
reactive with platelets and endothelial cells (Lin et al., 2012).
Recently, evidence directly linking soluble NS1 present in patient's
sera, with plasma leakage and endothelial dysfunction was pub-
lished (Beatty et al., 2015; Modhiran et al., 2015). However, the
complete cascade of events leading to DHF and the full role played
by secreted NS1 in severe dengue pathogenesis is still unknown. In
addition, preincubation of hepatocytes with soluble NS1 enhances
the replicative capacity of these cells for DENV. This and other data
suggest a role for NS1 in the modulation of innate immune
responses (Alcon-LePoder et al., 2006; Akey et al., 2014). Inter-
estingly, passive administration of NS1 antibodies protects mice
from dengue infection, presumably by antibody mediated cell lysis
of infected cells (Schlesinger et al., 1987; Amorim et al., 2014;). In
agreement, immunization of mice with vaccinia viruses expressing
NS1 confers protection against lethal dengue infection encephalitis
(Falgout et al., 1990).
Despite the fact that ﬂaviviruses cycles between vertebrate and
invertebrate hosts, the notion is well established in the ﬁeld that
NS1 is secreted only by cells of vertebrates and not by mosquito
cells (Muller and Young, 2013; Alcon-LePoder et al., 2006). The
notion is primarily based on observations made by Mason (1989)
who did not detect NS1 in the culture ﬂuid of 3 mosquito cell lines,
including C6/36 cells, infected with Japanese encephalitis virus
(JEV), while NS1 was readily detected in culture ﬂuids from
infected Vero cells. The inability to synthetize complex oligo-
saccharides was pointed as the possible cause for the retention of
NS1 within the mosquito cell (Mason, 1989). However, recent
results by us and others challenge this notion and suggest that
DENV NS1 is indeed released by infected mosquito cells. The
presence of NS1 has been detected in the supernatant of C6/36
cells infected with the different DENV serotypes using a com-
mercial ELISA or persistently infected C6/36 cells with DENV2
(Ludert et al., 2008; Ramirez et al., 2009; Juarez-Martinez et al.,
2013). Keelapang et al. (2004) also observed the presence of NS1 in
the supernatants of DENV infected C6/36 cells, as part of experi-
ments aimed to study the inﬂuence of charged residues on prM
cleavage. Likewise, recombinant NS1 expressed by baculovirus
vectors is readily secreted by Sf9 cells (Muller et al., 2012; Akey
et al., 2014). In support, Youn et al. (2010) observed that the
introduction of 2 DENV NS1 aminoacids (RQ10NK) into the amino
terminal region of West Nile Virus (WNV) NS1, resulted in the
accumulation of NS1 in the supernatant of WNV infected C6/36
cells. Nonetheless, the possibility exists that the presence of NS1 in
the supernatants of infected cells may only be the consequence of
cells lysis (Muller and Young, 2013). Thus, the aim of this work was
to evaluate this question in deep. Our results indicate that that NS1is released efﬁciently by cultured mosquito cells from either
Aedes albopictus or Aedes aegypti infected with DENV2 or 4 in the
absence of any signiﬁcant cell lysis.Materials and methods
Viral stocks
DENV serotype 4 (DENV4) strain 4H241 and DENV serotype 2
(DENV2) strain 16681, generously provided by Dr. Richard Kinney
(CDC, Fort Collins, CO), were propagated in suckling mice brain as
previously described (Gould and Clegg, 1991). Virus titers in mice
brain homogenates were determined by plaque assay in BHK-21 as
described by Ludert et al. (2008).
Cells
C6/36HT cells (derived from the C6/36 Aedes albopictus cells but
adapted to grow at 34 °C), kindly provided by Dr. Goro Kuno (CDC,
Puerto Rico), were grown in MEM, supplemented with 7% fetal calf
serum, nonessential aminoacids, vitamins, 0.370 g/l sodium
bicarbonate, 50 U/ml of penicillin and 50 μg/ml of streptomycin at
34 °C. Aag2 cells, a cell line derived from Aedes aegypti embryos
(Lan and Fallon, 1990), kindly provided by Dr. Isabel Salazar
(Instituto Politécnico Nacional, Mexico), were grown in Schneider
´s medium supplemented with 7% fetal calf serum (Invitrogen) and
50 U/ml of penicillin and 50 μg/ml of streptomycin at 28 °C.Vero
cells were grown in Dulbecco's modiﬁed Eagle medium (D-MEM
Advanced GibcoRL) supplemented with 8% fetal calf serum (Gibco-
BRL), 2 mM L-glutamine, 1.5 g/l sodium bicarbonate, 50 U/ml of
penicillin and 50 μg/ml of streptomycin. BHK21 cells were grown
in minimal essential medium (MEM, Gibco-BRL) supplemented
with 10% fetal calf serum (GIBCO-BRL), 2 g/l sodium bicarbonate,
50 U/ml of penicillin and 50 μg/ml of streptomycin. Vero and BHK-
21 cell lines were grown and maintained in a 5% CO2 atmosphere.
Measurement of secreted NS1 protein
The PlateliaTM NS1 Ag (Bio-Rad, Hercules,CA) commercial kit
was used to determine the levels of soluble NS1 in cell super-
natants. PlateliaTM is a one-step sandwich format microplate
enzyme immunoassay for the qualitative or semi-quantitative
detection of dengue NS1 antigen in human sera or plasma. The
test uses monoclonal antibodies for antigen capture and revela-
tion. The assay was carried out following the procedure indicated
by the manufacturer.
Viral infections
All experimental infections, either with DENV2 or DENV4, were
carried out at a multiplicity of infection of 3 (MOI¼3). Cell
monolayers grown to about 80% conﬂuence, were washed once
with Hank's medium (GIBCO) after the removal of grow medium.
The viral inoculum was added and cells incubated for 1 h at the
appropriate growth temperature for each cell line. Afterwards, the
inoculum was removed, the monolayer washed twice with Hank's
medium, enough medium to cover the monolayer added and the
cells incubated at the growth temperature for the time required
for each experiment.
Determination of cellular viability
Viability of infected C6/36HT, Aag2 and Vero cells was deter-
mined at 3, 6, 12, and 24 hpi by different methods, aimed to detect
either live or death cells, used following standard protocols. Mock
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trypan blue staining, cell monolayers were resuspended in PBS
and diluted 1:2 in trypan blue solution (0.4% in PBS). Five minutes
after incubation, an aliquot of 10 ml of the suspension was loaded
onto a Neubauer chamber to count live and dead cells. Viability
was determined by the percentage of live cells (excluding the
stain) of total cells counted. For neutral red staining, cell mono-
layers were covered with a neutral red (Sigma Aldrich, St. Louis,
MO) solution (100 mg / ml, pH: 6.35) diluted in grow medium and
incubated for 2 h. After incubation with the stain, the monolayer
was washed twice with PBS and incubated for 10 min at room
temperature under gentle shaking with elution medium (50:1
ethanol:acetic acid in water). Aliquots (60 ml) of the resulting
solutions were transferred to a 96-well and plate absorbance
measured at 540 nm. To obtain the percentage of damaged cell,
the following formula was applied: %DC¼100O.D. (infected
cells)100/O.D. (mock infected cells). Cell viability was deter-
mined by subtracting 100%GI. CellTiter 96s AQueous One
Solution Cell Proliferation Assay (MTS) (Promega, Madison, WI),
LDH Cytotoxicity Assay Kit (Cayman Chemical, Ann Harbor, MI) or
LDH CytoTox 96s (Promega, Madison, WI) and SYTOXs Orange
Nucleic Acid Stain (Life Technologies, Carlsbad, CA) were carried
out in cells grown on 96-well plates according manufacturer’s
instructions. Spectrophotometric measurements were carried out
in a Biotek Spectrophotometer (ELx808, USA).
Immunoﬂuorescence assays
C6/36HT cells were grown on 13 mm diameter coverslips
placed into 24-well plates. Once the cells reached conﬂuence, cells
were either infected with DENV or mock infected and at different
times post infection stained for immunoﬂuorescence. Brieﬂy, cell
monolayers were washed twice with PBS and ﬁxed for 20 min
with 4% paraformaldehyde (Merck, Darmstadt, Germany). The
ﬁxed monolayers were washed 3 times with PBS and permeabi-
lized or not in cold acetone for 5 min. Following 3 washes with
PBS, cells were blocked for one hour at room temperature with
blocking solution (1X PBS, 10% FBS, 3% BSA and 10 mM glycine).
Cells were incubated with rabbit hyperimmune anti-NS1 serum (a
gift from Ronaldo Mohana, Universidad Federal de Rio de Janeiro,
Brazil) or commercial anti-NS1 monoclonal antibodies (Thermo
Scientiﬁc, Waltham, MA; Abcams, Cambridge, UK) in diluent
solution (3% FBS, 1% BSA and 10 mM glycine in PBS) as primary
antibodies, overnight at 4 °C. Afterward, slides were washed
5 times with PBS and incubated for 2 h at room temperature with
anti-rabbit Alexa-647 or anti-mouse Alexa 488 (Invitrogen, Wal-
tham, MA) in diluting solution as secondary antibody. When
assembling, the coverslips were inverted on 2 ml of the compound
DAPI (4'6-diamidino-2-phenylindole) to stain nuclei. The cover
slips were sealed with nail polish and visualized in a LSM 700
confocal microscope (Carl Zeiss AG, Jena, Germany). Images were
processed using the program ZEN lite 2012 (Carl Zeiss AG, Jena,
Germany).
Cell cytometry
To assay for the presence of NS1 on the plasma membrane
surface by cell cytometry, C6/36HT (n¼3) or Vero cells (n¼2)
grown on 6 well plates were infected with DENV at a MOI¼3 and
harvested at 24 hpi. Mock infected cell were harvested in parallel
as controls. Cells were ﬁxed with 4% paraformaldehyde in PBS for
20 min. at room temperature and either permeabilized or not with
0.1% Triton X-100 in PBS and blocked with 10% fetal calf serum in
PBS, also for 30 min at room temperature. For cell labeling, an anti-
NS1 commercial Mab (Thermo Scientiﬁc) was used as primary
antibody and a FITC-conjugated goat anti-mouse IgG Mab (JacksonImmunoResearch, West Grove PA) as secondary antibody. After
each step, cells were washed once with PBS by low speed cen-
trifugation. Ten thousand events per sample were counted in a
FACS Calibur (Becton Dickinson) and the results analyzed using the
software FlowJow.
Western blot
The presence of NS1 in a hexameric form in the supernatant of
DENV4 infected C6/36HT cells was evaluated by western blot after
chemical crosslinking to stabilize the hexamer (Flamand et al.,
1999). Supernatants collected from infected or mock infected cell
were concentrated by centrifugation at 5000 g for 30 min at 4 °C
in 100 K ﬁltration units (Ultracels, Millipore,Cork, Ireland). The
rationale to use 100 k ﬁlters, was the need to get rid of the albu-
min present in the fetal calf serum used to grow the cells and a
potent inhibitor of the cross-liking reaction. Chemical cross-
linking was carried out with 50 mM of DSG (disuccinimidyl glu-
tarate, spacer arm 7.7 Å, Thermo Scientiﬁc); the reactions were
incubated at 37 °C for 60 min. and quenching carried out with
50 mM of Tris pH 8.0 for 15 min. Supernatants collected at 24 hpi
from Vero infected cells were also analyzed as controls. Samples
were separated without heat denaturation by SDS-PAGE in a 5–
10% gradient gel and transferred to nitrocellulose membranes
according to standard protocols. The presence of NS1 protein was
revealed using a commercial anti-NS1 polyclonal antibody (Sigma
Aldrich) and an anti-rabbit IgG antibody conjugated to peroxidase
as a secondary antibody (Cell Signaling Technologies). Proteins
were visualized by chemiluminescence (Supersignals West Pico,
Thermo Scientiﬁc) according to the manufacturer's instructions.
Electron microscopy
For the localization of NS1 protein in infected C6/36HT cells,
conﬂuent monolayers, grown on 6 well plates, were infected with
DENV4 (MOI¼3) and ﬁxed at various times post-infection with 4%
paraformaldehyde and 0.1% glutaraldehyde, followed by dehy-
dration in graded ethanols. Cells were detached from the culture
dish by treating the monolayer with propylene oxide (Polysciences
Inc., Warrington, PA), cutting the cell monolayer borders with a
knife and picking up the monolayer with a spatula. Detached
monolayers were collected in a 1.5 ml microtube and washed
twice with an excess of proplyne oxide to remove any plastic left.
The samples were next embedded in LR White resin (Polysciences
Inc., Warrington, PA) as indicated by the manufacturer. Thin sec-
tions of 60 nm were cut with a diamond knife and picked upon
200-mesh nickel grids coated with formvar ﬁlms. Blockade of
unspeciﬁc sites was done by ﬂoating the grids for 1 h on 10% FCS
diluted in PBS. Next, grids were incubated overnight at 4°C on
drops of rabbit hyperimmune anti-NS1 serum (a gift from Ronaldo
Mohana, Universidad Federal de Rio de Janeiro, Brazil) diluted in
PBS, as primary antibody. Grids were then washed 5 times in PBS
and incubated for 1h at room temperature with goat anti-rabbit
IgG coupled to 10 nm gold nanoparticles (Ted Pella, Redding, CA)
diluted in PBS, as secondary antibody. As controls for the speciﬁ-
city of the gold labelling, infected cells ﬁxed at 24 hpi, were
incubated directly with the secondary labeled antibody and mock
infected cells were incubated with primary and secondary anti-
bodies. Finally, thin sections were contrasted with uranyl acetate
and lead citrate and observed at 80 kV in a Jeol JEM-1011 electron
microscope (Jeol Ltd., Tokyo, Japan).
To visualize the NS1 oligomers, supernatant of DENV4 infected
C6/36HT cells were concentrated by centrifugation at 5000 g for
30 min at 4 °C in 30 K ﬁltration units (Ultracels, Millipore, Cork,
Ireland) and aliquots (20 ml) were ﬂoated on collodion-carbon
coated grids, negatively strained with 2% uranyl acetate and
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from mock infected cells were processed in parallel as controls.
Atomic force microscopy
To analyze the structure of NS1 oligomers by atomic force
microscopy (AFM), aliquots (20 ml) from supernatant of DENV4
infected C6/36HT cells were air dried on a glass slide and the
samples scanned with an atomic force microscope (Autoprobe CP
Research, Thermo-microscopes) operating in contact mode. Cell
supernatants from mock infected C6/36HT were also analyzed as
controls. The microscope was equipped with a 5 mm scanner and a
100 Å radius silicon nitride tip, mounted on a 0.6 mm ultralevel
model ULCT-AUMT. A scan rate of 2–3 Hz, a force of 10 nM, and a
gain of 0.5 arbitrary units were used. Images and analysis of height
proﬁles and structures diameters were generated with proscan
software (version 1.5, Park Scientiﬁc Instruments, 1997).Table 1
Viability of dengue virus infected cells determined at 24 hpi by different methods.n
cell line (virus) Cell viability Assay
Trypan blue Neutral red MTS LDH Sytoxs
C6/36HT (DENV4) 9871 9772 9871 9572 9573
C6/36HT (DENV2) 9871 9671 9771 9772 ND
Aag2 (DENV4) 9771 9571 9671 9871 ND
Aag2 (DENV2) 9771 9671 9671 9871 ND
Vero (DENV4) 9872 9771 9871 9671 ND
Vero (DENV2) 9872 9771 9771 9671 ND
n Results are expressed as percentage of live cells. nZ3 for C6/36HT and Vero
cells and n¼2 for Aag2 cells.Results
Protein NS1 is released from infected mosquito cells lines
In order to establish the kinetics of appearance of NS1 in cell
supernatants of infected mosquito cells, C6/36HT and Aag2 cells
were infected with DENV serotypes 2 or 4 at an MOI¼3 and the
presence of NS1 in the supernatants determined using an com-
mercial ELISA at 3, 6, 12 and 24 hpi. Times beyond 24 hpi were not
evaluated in order to avoid the possibility of cell lysis due to
cytophatic effects. Vero cells were infected in parallel for com-
parison. For both C6/36HT and Aag2 infected cells, the presence of
soluble NS1 was detected in the supernatants starting at 6 hpi and
the amount of soluble NS1 increases steadily up to 24 hpi. Differ-
ences were observed in the levels of soluble NS1 in the mosquito
cells infected with DENV 2 or DENV4; yet the time of detection of
the protein were similar for both cell lines. Repetitions of the
kinetic of NS1 release experiments in regular C6/36 cells (grown at
28 °C) infected with DENV4, gave results similar to those obtained
with C6/36HT cells (data not shown). A different kinetic of NS1
appearance was observed for infected Vero cells; no soluble NS1
was detected in the supernatants until 24 hpi after sharp increase
in the amount of soluble NS1 observed between 12 and 24 hpi
(Fig. 1).
In addition to NS1 levels, virus yield was determined by plaque
titration in the supernatants collected at 24 hpi. Average titers for
DENV2 and DENV4 in C6/36HT cells were 1 and 2x104 PFU/ml,
respectively; for Agg2 cells were 1 and 1.5104 PFU/ml while the
average titer for both serotypes in Vero cells was 1105 PFU/ml.C6/36 Aag2
O
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Fig. 1. Presence of protein NS1 in cell supernatants of mosquito and vertebrate cells in
infected with either DENV2 or DENV4 at a MOI¼3. Cells supernatants were collecte
commercial ELISA. nZ3.Protein NS1 release takes place in the absence of signiﬁcant cyto-
pathic effect
Although the presence of soluble NS1 in the supernatants of
infected mosquito cells is readily detected even at early times post
infection, the possibility exist that such a presence is due to the
liberation of NS1 by cells lysis and not an authentic secretory
process (Muller and Young, 2013). To address this question, the
viability of infected cells was evaluated at 24 hpi using several
methods, either based of live or dead cell determination. As shown
in Table 1, cell viability for DENV infected cells was found to be
over 96% in all cases, suggesting that not signiﬁcant cells lysis
occurred in any of the infected cells at this time post infection.
Similarly, cell viability evaluation of infected regular C6/36 cells
measured at 24 hpi, showed over 90% of cell viability (data not
shown). Since the amount of soluble NS1 increased over time
starting at 6 hpi, cell viability was evaluated for C6/36HT infected
with DENV4 at 3, 6, 12, and 24 hpi. If the increased presence of
soluble NS1 in cells supernatants is due liberation after cell lysis, a
decrease in cell viability should be observed over time in infected
cells starting at around 6 hpi. However, as shown in Table 2, no
signiﬁcant change in cell viability was observed in the infected C6/
36HT cells along any of the post infection times evaluated. More-
over, no evidence for cytopathic effect was observed in C6/36HT
cell monolayers infected with DENV4 and analyzed by phase
contrast microscopy at 3, 6, 12 at 24 hpi. Taken together, these
results indicate that the presence of soluble NS1 in the super-
natant of infected mosquito cells do not respond to the liberation
of the protein by cell lysis.
NS1 is not associated with plasma membrane of infected mosquito
cells
In infected vertebrate cells, protein NS1 is found, in addition to
its intracytoplasmatic location, associated to the outer face of theVero
12 24 0 6 12 24 
.i.p.h.i.p.h
DENV4 
DENV2 
fected with dengue virus. C6/36HT cells (A), Aag2 cells (B) and Vero cells (C) were
d at different times post infection and the presence of NS1 determined using a
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2013). In order to examine if NS1 is associated with the plasma
membrane of infected mosquito cells infected C6/36HT cells were
ﬁxed at 24 hpi and observed by confocal microscopy after acetone
permeabilization treatment or not. While the presence of the
protein NS1 was readily observed in the cytoplasm of permeabi-
lized cells, not signal was observed in the non-permeabilized cells
either stained with anti-NS1 hyperinmune sera (Fig. 2) or com-
mercial anti-NS1 monoclonal antibodies (data not shown). At
variance, signal for the protein NS1 was observed in either per-
meabilized or not permeabilized infected Vero cells, used as con-
trol (Fig. 2). The microscopy results altogether suggest that protein
NS1 is not associated with the outer face of plasma membrane in
infected mosquito cells.
The presence of NS1 on the outer plasma membrane of infected
C6/36HT cells was also assessed by cell cytometry in cells har-
vested at 24 hpi. Vero cells were run in parallel for comparison. In
agreement with the data obtained by confocal microscopy, little
signal above background levels was observed on the surface of
non-permeabilized infected C6/36HT cells, suggesting the absence
of NS1 on the outer plasma membrane. As expected, ﬂuorescenceTable 2
Viability of dengue virus 4 infected C6/36 cells determined at different times post
infection.n
Cell viability assay
hpi Trypan blue Neutral red LDH
3 9871 9871 9971
6 9971 9771 9871
12 9971 9771 9871
24 9871 9772 9871
n Results are expressed as percentage of live cells nZ3.
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Fig. 2. Confocal microscopy of C6/36HT and Vero cells infected with dengue virus. C6/3
permeabilized or not with acetone and stained for NS1 using rabbit anti-NS1 hyperimm
secondary antibody. Mock infected cells were stained in parallel as negative controls. Cwas detected on the surface on non-permeabilized Vero cells and
also in both cells lines when permeabilized (Fig. 3).
To corroborate the results obtained by confocal microscopy and
cell cytometry, DENV4 infected C6/36HT cells ﬁxed at 6, 12 at
24 hpi were analyzed by immunoelectron microscopy. Membrane
structures alteration induced by the infection, such as membrane
vesicles and packages were observed in the infected cells (Junjhon
et al., 2014). The presence of the protein NS1 was evident in the
cytoplasm of the cells ﬁxed at 6, 12 or 24 hpi (Fig. 4, panels A, B
and C). Few or no gold nanoparticles were observed in infected
cells ﬁxed at 24 hpi and incubated directly with the secondary
gold labeled antibody (Fig. 4, panel D) or in mock infected cells
incubated with primary and secondary antibodies (Fig. 4, panel E),
indicating the speciﬁcity of the mark. The NS1 protein was present
in the cytoplasm associated membranes vesicles, inside vacuoles-
like structures and in the nuclei. In agreement with previous
observations (Mackenzie et al., 1996), the presence of protein NS1
inside vacuoles-like structures was particularly evident at 24 hpi.
However, no gold particles were observed on the surface of the
cells, again indicating that the protein NS1 is not associated with
the plasma membrane in infected mosquito cells.
Released NS1 is a barrel shaped hexamer
Secreted protein NS1 from vertebrate infected cells is a hex-
amer with an open barrel shaped structure (Flamand et al., 1999;
Gutsche et al., 2011). Also, recombinant protein NS1 released from
baculovirus infected cells is released as a hexamer with a barrel-
like organization (Muller et al., 2012). To evaluate the oligomeric
nature of the insect cells secreted form of NS1, crosslinked pre-
parations from supernatants collected at 24 hpi were analyzed by
western blot (Fig. 5). Bands of apparent molecular weights of over
250 kD and 100 kD, compatible with the hexameric and dimeric
forms of NS1 respectively, were observed in infected C6/36HT and
also in Vero cell supernatants, analyzed as controls. Meanwhilemock DENV4 
Vero cells 
25µm 
6 and Vero cells were infected with DENV4 at a MOI¼3. At 24 hpi cells were ﬁxed,
une sera as primary antibody and with anti-rabbit conjugated with Alexa 647, as
ells nuclei were counterstained with DAPI.
 Vero 
N
O
N
-
PE
R
M
EA
B
IL
IZ
ED
 
PE
R
M
EA
B
IL
IZ
ED
 
 C6/36 
NS1-FITC 
Fig. 3. Cell cytometry of C6/36HT and Vero cells infected with dengue virus. Conﬂuent monolayers of C6/36 and Vero cells infected with DENV4 (MOI¼3) were harvested at
24 hpi, ﬁxed with paraformaldehyde and permeabilized or not with Triton X-100. Single cell suspensions were stained for NS1 protein using a commercial Mab as primary
antibody and an FITC-conjugated anti-mouse IgG as secondary antibody (1þ2). Cells incubated with only the secondary (2) antibody were included as controls. Upper right
panel shows the selected gate conditions and the upper left hand panel the region used to determine mean ﬂuorescence intensity (MFI). Individual histograms for each
condition indicating MFI and percentage of positive cell are presented at the bottom panels.
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Fig. 4. Immunoelectron microscopy of C6/36HT cells infected with dengue virus. Mosquito cells were infected with DENV4 at a MOI¼3 and at 6 (A), 12 (B) and 24 hpi (C),
cells were ﬁxed and labeled for protein NS1 using anti-NS1 hyperimmune sera and anti-rabbit IgG antibodies conjugated to 10 nm gold particles. Infected cells ﬁxed at 24 hpi
and incubated directly with goat anti-rabbit IgG coupled to 10 nm gold particles (D) or mock infected cell incubated with anti-NS1 hyperimmune sera and anti-rabbit IgG
antibodies conjugated to 10 nm gold particles (E) were used as controls. Solid arrows indicate seeming virus induced membrane vesicles.
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Fig. 5. Crosslinking of secreted protein NS1 from dengue virus infected mosquito cells. Concentrated supernatants of C6/36HT (A) and Vero (B) dengue virus infected or
mock infected cell were cross-linked with 50 mM of DSG. Concentrated supernatant from infected cells, without crosslinking was included as control. Proteins were
separated without heat denaturation on a 5–10 % gradient SDS-polyacrylamide gel and visualized by western blot. Bands corresponding to NS1 hexamers and dimers are
indicated. The extra band observed in the cross-linked Vero cells supernatant may correspond to previously reported tetrameric forms. Molecular weight markers are shown
on the left.
10 nm 
100 nm 
Fig. 6. Electron microscopy image of secreted protein NS1 from dengue virus infected C6/36HT mosquito cells. Supernatants from mock (A) or DENV infected C6/36HT cells
(B, C, and D) were collected at 24 hpi, concentrated using centrifugal ﬁlter units and negatively stained with uranyl acetate. Label in panel C shows the diameter of an
observed dengue virion included as size reference. Black circles in panels B and C enclosed alleged protein NS1 hexamers.
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Fig. 7. Visualization of secreted NS1 protein from dengue virus infected C6/36HT mosquito cells by atomic force microscopy. Panel A, height proﬁle from infected cell
supernatants. Black circles enclose alleged NS1 hexamers. Panels B and C, enlargement of selected structures from panel A showing images presumably viewed from 3 fold
and 2 fold axes of symmetry, respectively. Panel D, height proﬁle from mock infected cell supernatants.
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in agreement with the labile nature reported for the hexameric
structure (Flamand et al., 1999). No bands were observed in the
supernatant of mock infected cells.
In order to analyze the structural organization of the released
form of the protein NS1 from infected mosquito C6/36HT cells,
supernatants from infected cells collected at 24 hpi and con-
centrated by ﬁltration were negatively stained and observed by
electron microscopy. The presence of particulate electron dense
material was observed in the cell supernatants of infected cells but
not in the supernatants of mock infected cells, used as controls
(Fig. 6, panels A, B, C). Upon closer examination, these electron
dense particles showed a diameter of approximately 10 nm and
ultraestructural details similar with the barrel-like conformation
described for the hexameric form of the protein NS1 (Fig. 6, panel
D). To corroborate these results, concentrated material was also
analyzed by AFM. The height proﬁles showed structures with 3-
fold symmetry and a central depression (Fig. 7, panels A and B) as
well as elongated structures with lobular contours (Fig. 7, panels A
and C), both with approximately 10 nm in diameter and reminis-
cent of the 3 and 2-fold tridimensional reconstructions of the NS1
hexamer reported for NS1 released from vertebrate cells (Gutsche
et al., 2011). These structures were not observed in the super-
natants collected from the mock infected cells (Fig. 7, panel D).
Thus, the chemical cross-linking taken together with the electro
and atomic force microscopy data indicate that NS1 is secreted
from DENV infected mosquito cells also as a barrel-like hexamer.Discussion
In this manuscript evidence is presented indicating that the
DENV NS1 protein is secreted efﬁciently from infected mosquito
cells of the species A. albopictus and of the A. aegypti infected with
at least 2 serotypes of DENV. This ﬁnding contradicts the notion
established in the ﬁeld stating that NS1 protein was only secreted
by infected cells from vertebrates (Muller and Young, 2013). The
NS1 protein was detected in the infected cells supernatants using a
commercial assay, intended for the diagnosis of dengue in
humans, based on the detection of NS1 in patients' sera, in the
absence of any signiﬁcant cells lysis as determined by several
viability methods, including methods aimed to detect lysed or
dead cells. Moreover, the dissociation observed between the
increases in NS1 concentration, starting at 6 and up to 24 hpi, in
the supernatants and the number of detected dead cells indicates
that the presence of NS1 in the supernatants of the infectedmosquito cells is the result of a secretory process and not the
results of NS1 liberation after cells lysis. The production of soluble
NS1 antigen in patients or in animal models is virus strain and
host dependent (Alcon-LePoder et al., 2006; Watanabe et al.,
2012). The observed variances between released NS1 levels from
DENV serotype 2 and 4 and C6/36 and Aag2 cells suggest that the
same is true in infected insect cells. Although qualitative differ-
ences are not to be expected, it will be interesting to compare NS1
secretion kinetics from insect cells using strains from different
serotypes or clinical isolates. Of note, clear differences were
observed in the kinetics of NS1 presence in the cells supernatants
of infected mosquito and Vero cells used for comparison. For Vero
cells no NS1 was detected in the cell supernatant before 12 hpi. A
similar kinetics for NS1 secretion has also been observed for
infected human hepatic (Huh-7) cells infected with several DENV
2 strains (Watanabe et al., 2012) and for DENV 2 infected Vero cells
(Ludert et al., 2008). The reasons for such differences in NS1
protein secretion between mosquito and vertebrate cells are
unknown, but may merely reﬂects difference in grow rates of the
viral strains used in both cell types. Yet they may also indicate that
fundamental differences exist in the way NS1 is released from both
cell types.
The notion that NS1 was not secreted from ﬂavivirus mosquito
cells was established after the pioneering work by Mason (1989). In
that work, after infecting mammalian (Vero) and mosquito (C6/36,
AP61, TRA284) cell lines with Japanese encephalitis virus, the
author observed that both E and NS1 proteins were released from
the infected Vero cells while only the E protein was released from
the infected mosquito cells lines. NS1 protein was produced abun-
dantly in the insect cells but remained cells associated. Differences
in the glycoprotein synthesis pathways between vertebrate and
invertebrate cells and the inability of mosquito cells to generate
complex oligosaccharides was pointed as the reason for the reten-
tion of JEV NS1 protein inside the cells. Although the NS1 protein is
relatively well conserved among ﬂaviviruses (Muller and Young,
2013; Akey et al., 2014); differences in the amino acid sequences
between the NS1 proteins encoded by JEV and DENV most likely is
the explanation for the discrepant results between this and Mason's
work. Youn et al. (2010) in a study aimed to determine the genetic
basis for ﬂavivirus NS1 protein cell targeting, generated a series of
NS1 chimeras between WNV and DENV and found that amino acid
position 10 was critical for directing plasma membrane targeting
and secretion of the NS1 proteins for both ﬂaviviruses. By mutating
this single amino acid position (Asn to Asp), a decreased in the
expression of the WNV NS1 protein on the plasma surface of BHK21
and an increase in secretion was observed. Interestingly, the
A.C. Alcalá et al. / Virology 488 (2016) 278–287286introduction of DENV amino acids Asn and Lys in substitution for
WNV amino acid Arg and Glu at positions 10 and 11 resulted in the
secretion of WNV NS1 protein into the supernatants of C6/36 cells.
Both JEV and WNV, as well as other ﬂaviviruses, present the amino
acid Arg at position 10, while DENV present Asp or Gly at this
position, depending on the serotype. It will be interesting to test if
the replacement of position 10 of JEV for DENV aminoacids will also
result in JEV NS1 secretion from insect cells, as have been observed
for WNV (Youn et al., 2010).
In infected vertebrate cell in addition to its cytoplasmic loca-
tions, the NS1 protein is also found on the outer face of the plasma
membrane, either as a result of transportation fromwithin the cell,
by as yet unknown route, or as a result of “binding back” of soluble
NS1 protein (Avirutnan et al., 2007; Muller and Young, 2013). Our
attempts to detect NS1 on the cell surface of infected C6/36HT
cells, either by confocal microscopy, cell cytometry or immunoe-
lectron microscopy fail to reveal the presence of NS1 on the
plasma membrane of infected cells. Since a hyper immune serum
was used for the confocal and electronmicroscopy assays, and a
commercial Mab for the cytometry assay and several NS1 antigenic
epitopes are readily exposed (Edeling et al., 2013), lack of recog-
nition due to differences in epitopes conformation or epitope
accessibility seems unlikely. In agreement, Junjhon et al. (2014), in
studying the distribution of NS1 in infected mosquito cells,
observed NS1 located only to the perinuclear region, with a dis-
tribution pattern similar to the C protein. An inverse correlation
between cell surface expression and secretion of NS1 for DENV
and WNV has been observed (Youn et al., 2010). Thus, the high
efﬁciency of NS1 secretion from insect cells may result in little or
no exposure of NS1 on the cell surface. The attachment of the NS1
protein to the vertebrate cells plasma membrane is mediated by
GPI linkage acquired during the transit of the protein thought the
Golgi apparatus (Noisakran et al., 2008). The absence of NS1 on the
plasma membrane on infected mosquito cells suggests differences
in the trafﬁc route for NS1 between mosquito and vertebrate cells.
The attachment of NS1 to vertebrate cells has been reported to be
mediated by glycosaminoglycans and to show speciﬁcity for cer-
tain cell types (Avirutnan et al., 2007). The origin of the C6/36 cell
line is unknown, and the capacity of secreted NS1 to bind to other
insect cell lines needs to be evaluated.
In addition, immunoelectron microscopy revealed the presence
of NS1 in the nucleus and the nucleolus of the infected cells, even
at 6 hpi. This was an unexpected ﬁnding since no nuclear locali-
zation signals are present in the sequence of NS1. However, evi-
dence for the presence of NS1 in the nucleus is seen in the images
taken by confocal microscopy by us and also by immuno-
ﬂuorescence microscopy by Junjhon et al. 2014 in infected mos-
quito cells. Also the presence of NS1 is noticed in the nucleus of
BHK-21 cells transfected with in vitro transcribed RNA (Akey et al.,
2014). The presence of NS1 in the nucleus has been previously
reported in infected human endothelial cells using subcellular
fractionation and western blots (Poungsawai et al., 2011). The
importance of NS1 presence in the cell nuclei of insect or endo-
thelial cells remains to be determined.
The analysis by electron microscopy and AFM of concentrated
secreted material from infected cells revealed the presence of
particulate matter with size and ultrastructural characteristics
fully compatible with the barrel-shaped structure reported for
hexameric NS1 secreted from infected vertebrate cells or insect
cells transfected with recombinant baculovirus (Gutsche et al.,
2011; Muller et al., 2012; Akey et al., 2014). These results, com-
bined with the western blot result of cross-linked material, indi-
cate that NS1 is secreted from infected insect cells also as an open
barrel shaped hexamer. In agreement, previous observations by us
showed that soluble protein NS1 present in infected mosquito cell,
and vertebrate cells, supernatants is no longer recognized by thedengue NS1 PLATELIA™ assay if the sample is boiled, suggesting
the oligomeric nature of the protein NS1 present in the super-
natants (data not shown). The abundance presence of hexameric
NS1 in the cell supernatants argues in favor of soluble NS1 being
secreted, and not released after cells lysis, from the infected insect
cells. Insect cells markedly differ from vertebrate cells in choles-
terol and lipids metabolism as well as glycoprotein processing.
Thus, it is likely that the lipid composition will differ signiﬁcantly
between hexamers released from insect and vertebrates cells.
Likewise, although both protein NS1 asparagine residues 130 and
207 of NS1 are likely to be recognized and glycosylated in the
insect cells, differences in oligosaccharide processing and the
absence of complex oligosaccharides are to be expected in the
secreted hexamer from the insect cells (Hsieh and Robbinst, 1984).
The DENV NS1 is an intriguing protein whose importance for
virus replication and pathogenesis is well established; yet much is
still to be known about its functions or mechanisms of action. The
observed efﬁcient secretion of protein NS1 from infected mosquito
cells maintained in vitro if conﬁrmed in intact mosquitoes would
open new avenues into the role of NS1 in the replication cycle, the
biology and the pathogenesis of DENV infections. Questions about
the participation of extracellular NS1 in the infection of the mos-
quito or its role in the infection of the vertebrate host will need to
be answered.Acknowledgments
This work was partially supported by a Miguel Alemán A.C.
Foundation award to JEL. ACA is a recipient of a scholarship from
CONACYT, México. We like to thank Dr. Luis Donis Maturano for his
help in the analysis of the cell cytometry data.References
Akey, D.L., Brown, C., Dutta, S., Konwerski, J., Jose, J., Jurkiw, T.J., Del Proposto, J.,
Ogata, C.M., Skiniotis, G., Kuhn, R.J., Smith, J.L., 2014. Flavivirus NS1 crystal
structures reveal a surface for membrane association and regions of interaction
with the immune system. Science 343, 881–885.
Alcon-LePoder, S., Sivard, P., Drouet, M.T., Talarmin, A., Rice, C., Flamand, M., 2006.
Secretion of ﬂaviviral non-structural protein NS1: from diagnosis to patho-
genesis. Novartis Found. Symp. 277, 233–247.
Amorim, J.H., Alves, R.P., Boscardin, S.B., Ferreira, L.C., 2014. The dengue virus non-
structural 1 protein: risks and beneﬁts. Virus Res. 181, 53–60.
Avirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auetha-
vornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C.,
Pattanakitsakul, S.N., Yenchitsomanus, P.T., Mongkolsapaya, J., Kasinrerk, W.,
Sittisombut, N., Husmann, M., Blettner, M., Vasanawathana, S., Bhakdi, S.,
Malasit, P., 2006. Vascular leakage in severe dengue virus infections: a potential
role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193,
1078–1088.
Avirutnan, P., Zhang, L., Punyadee, N., Manuyakorn, A., Puttikhunt, C., Kasinrerk, W.,
Malasit, P., Atkinson, J.P., Diamond, M.S., 2007. Secreted NS1 of dengue virus
attaches to the surface of cells via interactions with heparan sulfate and
chondroitin sulfate E. PLoS Pathog. 3, 1798–1812.
Beatty, P.R., Puerta-Guardo, H., Killingbeck, S.S., Glasner, D.R., Hopkins, K., Harris, E.,
2015. Dengue virus NS1 triggers endothelial permeability and vascular leak that
is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141.
Clyde, K., Harris, E., 2006. RNA secondary structure in the coding region of dengue
virus type 2 directs translation start codon selection and is required for viral
replication. J. Virol. 80, 2170–2182.
De la Cruz, S.I., Flores-Aguilar, H., González-Mateos, S., López-Martinez, I., Alpuche-
Aranda, C., Ludert, J.E., del Angel, R.M., 2013. Determination of viremia and
concentration of circulating nonstructural protein 1 in patients infected with
dengue virus in Mexico. Am. J. Trop. Med. Hyg. 88, 446–454.
Edeling, M.A., Diamond, M.S., Fremont, D.H., 2013. Structural basis of Flavivirus NS1
assembly and antibody recognition. Proc. Natl. Acad. Sci. USA 111, 4285–4290.
Falgout, B., Bray, M., Schlesinger, J.J., Lai, C.J., 1990. Immunization of mice with
recombinant vaccinia virus expressing authentic dengue virus nonstructural
protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64,
4356–4363.
A.C. Alcalá et al. / Virology 488 (2016) 278–287 287Fan, W.F., Mason, P.W., 1990. Membrane association and secretion of the Japanese
encephalitis virus NS1 protein from cells expressing NS1 cDNA. Virology 2,
470–476.
Flamand, M., Megret, F., Mathieu, M., Lepault, J., Rey, F.A., Deubel, V., 1999. Dengue
virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells
as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73,
6104–6110.
Gould, E., Clegg, J., 1991. Growth, Titration and Puriﬁcation of Alphaviruses and
Flaviviruses. Virology: A Practical pp. IRL Press, Oxford, United Kingdom, pp.
43–78, Approach.
Gutsche, I., Coulibaly, F., Voss, J.E., Salmon, J., d´Alayer, J., Ermonval, M., Larquet, E.,
Charneau, P., Krey, T., Megret, F., Guittet, E., Rey, F.A., Flamand, M., 2011.
Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped
high-density lipoprotein. Proc. Natl. Acad. Sci. USA 108, 8003–8008.
Halstead, S.B., 2013. Dengue vascular permeability syndrome: what, no T cells? Clin.
Infect. Dis. 56, 900–901.
Hsieh, P., Robbinst, P.W., 1984. Regulation of asparagine-linked oligosaccharide
Processing. J. Biol. Chem. 259, 2375–2382.
Juarez-Martinez, A.B., Vega-Almeida, T.O., Salas-Benito, M., Garcia-Espitia, M., De
Nova-Ocampo, M., Del Angel, R.M., Salas-Benito, J.S., 2013. Detection and
sequencing of defective viral genome in C6/36 cells persistenly infected with
dengue virus 2. Arch. Virol. 158, 583–599.
Junjhon, J., Pennington, J.G., Edwards, T.J., Perera, R., Lanman, J., Kuhn, R.J., 2014.
Ultrastructural characterization and three-dimensional architecture of repli-
cation sites in dengue virus-infected mosquito cells. J. Virol. 88, 4687–4697.
Keelapang, P., Sriburi, R., Supasa, S., Panyadee, N., Songjaeng, A., Jairungsri, A.,
Puttikhunt, C., Kasinrerk, W., Malasit, P., Sittisombut, N., 2004. Alterations of pr-
M cleavage and virus export in pr-M junction chimeric dengue viruses. J. Virol.
78, 2367–2381.
Lan, Q., Fallon, A.M., 1990. Small heat shock proteins distinguish between two
mosquito species and conﬁrm identity of their cell lines. Am. J. Trop. Med. Hyg.
4, 669–676.
Libraty, D.H., Young, P.R., Pickering, D., Endy, T.P., Kalayanarooj, S., Green, S.,
Vaughn, D.W., Nisalak, A., Ennis, F.A., Rothman, A.L., 2002. Circulating levels of
the dengue virus nonstructural protein NS1 early in dengue illness correlate
with the development of dengue hemorrhagic fever. J. Infect. Dis. 15,
1165–1168.
Lin, S.W., Chuang, Y.C., Lin, Y.S., Lei, H.Y., Liu, H.S., Yeh, T.M., 2012. Dengue virus non-
structural protein NS1 binds to prothrombin/thrombin and inhibits pro-
thrombin activation. J. Infect. 64, 325–334.
Ludert, J.E., Mosso, C., Ceballos-Olvera, I., del Angel, R.M., 2008. Use of a commercial
enzyme immunoassay to monitor dengue virus replication in cultured cells.
Virol. J. 5, 51.Mackenzie, J.M., Jones, M.K., Young, P.R., 1996. Immunolocalization of the dengue
virus nonstructural glycoprotein NS1 suggest a role in viral RNA replication.
Virology 220, 232–240.
Mason, P.W., 1989. Maturation of Japanese encephalitis virus glycoproteins pro-
duced by infected mammalian and mosquito cells. Virology 169, 354–364.
Modhiran, N., Watterson, D., Muller, D.A., Panetta, A.K., Sester, D.P., Liu, L., Hume, D.
A., Stacey, K.J., Young, P.R., 2015. Dengue virus NS1 protein activate cells via toll-
like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl.
Med. 7, 304ra142.
Muller, D.A., Landsberg, M.J., Bletchly, C., Rothnagel, R., Waddington, L., Hankamer,
B., Young, P.R., 2012. Structure of the dengue virus glycoprotein non-structural
protein 1 by electron microscopy and single-particle analysis. J. Gen. Virol. 93,
771–779.
Muller, D.A., Young, P.R., 2013. The ﬂavivirus NS1 protein: molecular and structural
biology, immunology, role in pathogenesis and application as a diagnostic
biomarker. Antivir. Res. 98, 192–208.
Noisakran, S., Dechtawewat, T., Avirutnan, P., Kinoshita, T., Siripanyaphinyo, U.,
Puttikhunt, C., Kasinrerk, W., Malasit, P., Sittisombut, N., 2008. Assosiation of
dengue virus 4 NS1 protein with lipid rafts. J. Gen. Virol. 89, 2492–2500.
Poungsawai, J., Kanlaya, R., Pattanakitsakul, S.N., Thongboonkerd, V., 2011. Sub-
cellular localizations and time-course expression of dengue envelope and non-
structural 1 proteins in human endothelial cells. Microbiol. Pathog. 51,
225–229.
Ramirez, A.H., Moros, Z., Comach, G., Zambrano, J., Bravo, L., Pinto, B., Vielma, S.,
Cardier, J., Liprandi, F., 2009. Evaluation of dengue NS1 antigen detection tests
with acute sera from patients infected with dengue virus in Venezuela. Diagn.
Microbiol. Infect. Dis. 65, 247–253.
Schlesinger, J.J., Brandriss, M.W., Walsh, E.E., 1987. Protection of mice against
dengue 2 virus encephalitis by immunization with the dengue 2 virus non-
structural glycoprotein NS1. J. Gen. Virol. 68, 853–857.
Watanabe, S., Tan, K.H., Rathore, A.P., Rozen-Gagnon, K., Shuai, W., Ruedl, C.,
Vasudevana, S.G., 2012. The magnitude of dengue virus NS1 protein secretion is
strain dependent and does not correlate with severe pathologies in the mouse
infection model. J. Virol. 86, 5508–5551.
Whitehorn, J., Simmons, C.P., 2011. The pathogenesis of dengue. Vaccine 42,
7221–7228.
Winkler, G., Randolph, V.B., Cleaves, G.R., Ryan, T.E., Stollar, V., 1988. Evidence that
the mature form of the ﬂavivirus nonstructural protein NS1 is a dimer. Virology
162, 187–196.
Youn, S., Cho, H., Fremont, D.H., Diamond, M.S., 2010. A short N-terminal peptide
motif on ﬂavivirus nonstructural protein NS1 modulates cellular targeting and
immune recognition. J. Virol. 84, 9516–9532.
